Ever since the COVID-19 vaccines were authorized for emergency use, researchers have been tracking the risk of myocarditis and pericarditis — another heart inflammation condition that affects the outer lining of the heart but has similar symptoms, such as chest pain, shortness of breath and a pounding heartbeat, according to the CDC.
In a recent study, Canadian researchers found that heart inflammation cases were two- to threefold higher after Moderna’s vaccine compared to Pfizer’s. The study concluded that the risk is still low, but multiple vaccine-makers will test their formulas for long-term health effects of myocarditis after COVID-19 vaccination, according to the CDC. The yearslong trials are set to begin in a few months.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
